{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:22:26Z","timestamp":1760746946710,"version":"build-2065373602"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03698-3","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:52:27Z","timestamp":1760705547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune cell dynamics and prognostic role of M2 macrophages and LDOC1 in colon adenocarcinoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Laibin","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"1","key":"3698_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3698_CR2","first-page":"198","volume":"21","author":"JC Fabregas","year":"2022","unstructured":"Fabregas JC, Ramnaraign B, George TJ. Clinical updates for colon cancer care in 2022. Clin Colorectal Cancer. 2022;21(3):198\u2013203.","journal-title":"Clin Colorectal Cancer"},{"key":"3698_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2119\/molmed.2016.00098","volume":"22","author":"MM Watson","year":"2016","unstructured":"Watson MM, S\u00f8reide K. The prognostic yield of biomarkers harvested in chemotherapy-naive stage II colon cancer: can we separate the wheat from the chaff? Mol Med. 2016;22:271\u20133.","journal-title":"Mol Med"},{"issue":"4","key":"3698_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s13353-023-00778-4","volume":"64","author":"D Chen","year":"2023","unstructured":"Chen D, et al. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes. J Appl Genet. 2023;64(4):713\u201321.","journal-title":"J Appl Genet"},{"key":"3698_CR5","doi-asserted-by":"crossref","unstructured":"Zhang X, et al. The tumor microenvironment: signal transduction. Biomolecules, 2024. 14(4).","DOI":"10.3390\/biom14040438"},{"key":"3698_CR6","doi-asserted-by":"publisher","first-page":"153303382312218","DOI":"10.1177\/15330338231221856","volume":"23","author":"J Li","year":"2024","unstructured":"Li J, et al. Deciphering the tumor microenvironment of colorectal cancer and guiding clinical treatment with Patient-Derived organoid technology: progress and challenges. Technol Cancer Res Treat. 2024;23:15330338231221856.","journal-title":"Technol Cancer Res Treat"},{"issue":"8","key":"3698_CR7","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides A, et al. The complex role of tumor-infiltrating macrophages. Nat Immunol. 2022;23(8):1148\u201356.","journal-title":"Nat Immunol"},{"key":"3698_CR8","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, et al. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877:173090.","journal-title":"Eur J Pharmacol"},{"key":"3698_CR9","doi-asserted-by":"publisher","first-page":"101041","DOI":"10.1016\/j.drup.2023.101041","volume":"73","author":"H Wang","year":"2024","unstructured":"Wang H, et al. The promising role of tumor-associated macrophages in the treatment of cancer. Drug Resist Updat. 2024;73:101041.","journal-title":"Drug Resist Updat"},{"key":"3698_CR10","doi-asserted-by":"crossref","unstructured":"Dussold C et al. Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer. J Clin Invest, 2024. 134(2).","DOI":"10.1172\/JCI175445"},{"key":"3698_CR11","doi-asserted-by":"publisher","first-page":"105880","DOI":"10.1016\/j.intimp.2019.105880","volume":"76","author":"L Sharifi","year":"2019","unstructured":"Sharifi L, et al. A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting. Int Immunopharmacol. 2019;76:105880.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"3698_CR12","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1080\/01443615.2022.2099736","volume":"42","author":"MP Jammal","year":"2022","unstructured":"Jammal MP, et al. Mast cells and M2 macrophages in ovarian cancer. J Obstet Gynaecol. 2022;42(7):3094\u2013100.","journal-title":"J Obstet Gynaecol"},{"key":"3698_CR13","doi-asserted-by":"publisher","first-page":"1103617","DOI":"10.3389\/fimmu.2023.1103617","volume":"14","author":"M Zhang","year":"2023","unstructured":"Zhang M, et al. Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer. Front Immunol. 2023;14:1103617.","journal-title":"Front Immunol"},{"key":"3698_CR14","doi-asserted-by":"crossref","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci, 2021. 22(13).","DOI":"10.3390\/ijms22136995"},{"key":"3698_CR15","doi-asserted-by":"crossref","unstructured":"Cersosimo F et al. Tumor-Associated macrophages in osteosarcoma: from mechanisms to therapy. Int J Mol Sci, 2020. 21(15).","DOI":"10.3390\/ijms21155207"},{"issue":"8","key":"3698_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1261\/rna.074922.120","volume":"26","author":"S Zhao","year":"2020","unstructured":"Zhao S, Ye Z, Stanton R. Misuse of RPKM or TPM normalization when comparing across samples and sequencing protocols. RNA. 2020;26(8):903\u20139.","journal-title":"RNA"},{"issue":"1","key":"3698_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li B, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016;17(1):174.","journal-title":"Genome Biol"},{"issue":"5","key":"3698_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"1","key":"3698_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13073-019-0655-5","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, et al. Correction to: Molecular and Pharmacological modulators of the tumor immune contexture revealed by Deconvolution of RNA-seq data. Genome Med. 2019;11(1):50.","journal-title":"Genome Med"},{"issue":"1","key":"3698_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13059-016-1113-y","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, et al. Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):249.","journal-title":"Genome Biol"},{"issue":"1","key":"3698_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"key":"3698_CR22","doi-asserted-by":"crossref","unstructured":"Racle J et al. Simultaneous Enumer Cancer Immune Cell Types Bulk Tumor Gene Expression Data Elife, 2017. 6.","DOI":"10.7554\/eLife.26476"},{"key":"3698_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"3698_CR24","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han Y, et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 2023;51(D1):D1425\u201331.","journal-title":"Nucleic Acids Res"},{"key":"3698_CR25","doi-asserted-by":"publisher","first-page":"103374","DOI":"10.1016\/j.critrevonc.2021.103374","volume":"163","author":"A Addeo","year":"2021","unstructured":"Addeo A, et al. TMB or not TMB as a biomarker: that is the question. Crit Rev Oncol Hematol. 2021;163:103374.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9\u2013s","key":"3698_CR26","first-page":"97","volume":"89","author":"GL De\u2019 Angelis","year":"2018","unstructured":"De\u2019 Angelis GL, et al. Microsatellite instability in colorectal cancer. Acta Biomed. 2018;89(9\u2013s):97\u2013101.","journal-title":"Acta Biomed"},{"issue":"2","key":"3698_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","volume":"39","author":"DL Jardim","year":"2021","unstructured":"Jardim DL, et al. The challenges of tumor mutational burden as an immunotherapy biomarker. Cancer Cell. 2021;39(2):154\u201373.","journal-title":"Cancer Cell"},{"issue":"6","key":"3698_CR28","first-page":"408","volume":"15","author":"F Wang","year":"2016","unstructured":"Wang F, et al. Tumor purity and differential methylation in cancer epigenomics. Brief Funct Genomics. 2016;15(6):408\u201319.","journal-title":"Brief Funct Genomics"},{"issue":"10","key":"3698_CR29","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"11","key":"3698_CR30","doi-asserted-by":"publisher","first-page":"e1195","DOI":"10.1371\/journal.pone.0001195","volume":"2","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y, et al. Subclass mapping: identifying common subtypes in independent disease data sets. PLoS ONE. 2007;2(11):e1195.","journal-title":"PLoS ONE"},{"issue":"Database issue","key":"3698_CR31","first-page":"D955","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"3698_CR32","first-page":"e59503","volume":"16","author":"A Abolghasemi Fard","year":"2024","unstructured":"Abolghasemi Fard A, Mahmoodzadeh A. Unraveling the progression of colon cancer pathogenesis through epigenetic alterations and genetic pathways. Cureus. 2024;16(5):e59503.","journal-title":"Cureus"},{"issue":"3","key":"3698_CR33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"issue":"1","key":"3698_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12964-021-00712-3","volume":"19","author":"C Ternet","year":"2021","unstructured":"Ternet C, Kiel C. Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage. Cell Commun Signal. 2021;19(1):31.","journal-title":"Cell Commun Signal"},{"issue":"7781","key":"3698_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","volume":"575","author":"J Canon","year":"2019","unstructured":"Canon J, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575(7781):217\u201323.","journal-title":"Nature"},{"issue":"4","key":"3698_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11684-018-0656-6","volume":"12","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Weinberg RA. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front Med. 2018;12(4):361\u201373.","journal-title":"Front Med"},{"issue":"2","key":"3698_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"3698_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3892\/ol.2022.13421","volume":"24","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. Prognostic value and potential biological functions of ferroptosis-related gene signature in bladder cancer. Oncol Lett. 2022;24(3):301.","journal-title":"Oncol Lett"},{"key":"3698_CR39","doi-asserted-by":"publisher","first-page":"105644","DOI":"10.1016\/j.phrs.2021.105644","volume":"169","author":"C Jiang","year":"2021","unstructured":"Jiang C, et al. In Silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma. Pharmacol Res. 2021;169:105644.","journal-title":"Pharmacol Res"},{"key":"3698_CR40","doi-asserted-by":"publisher","first-page":"1038927","DOI":"10.3389\/fimmu.2022.1038927","volume":"13","author":"C Liu","year":"2022","unstructured":"Liu C, et al. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Front Immunol. 2022;13:1038927.","journal-title":"Front Immunol"},{"key":"3698_CR41","doi-asserted-by":"publisher","first-page":"111107","DOI":"10.1016\/j.cellsig.2024.111107","volume":"117","author":"W Yang","year":"2024","unstructured":"Yang W, Liu Z, Liu T. Pan-cancer analysis predicts CANT1 as a potential prognostic, Immunologic biomarker. Cell Signal. 2024;117:111107.","journal-title":"Cell Signal"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03698-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03698-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03698-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:52:30Z","timestamp":1760705550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03698-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3698"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03698-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"23 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1915"}}